How AI is accelerating signal detection, adverse event triage, case processing, and safety reporting in pharmacovigilance operations.
AI in aggregate safety reporting: how to cut PBRER production time without cutting corners A Periodic Benefit-Risk Evaluation Report for a product with a large safety database can take a team of five people six to eight weeks to produce. That cycle repeats every year for every authorised product in your portfolio. For a biotech […]
AI signal detection tools are cutting ICSR processing time by 40 to 60 percent and enabling continuous literature monitoring that manual processes cannot match. The global PV market reached $8.99 billion in 2025. This article explains how biotech PV teams can deploy AI surveillance tools within GxP compliance requirements and where the firm data boundaries sit.
AI Signal Detection in Pharmacovigilance: Find the Safety Signal First Read More »
